State Street’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $115M | Sell |
|
|||||
|
2025
Q2 | $100M | Buy |
|
|||||
|
2025
Q1 | $106M | Sell |
|
|||||
|
2024
Q4 | $80.1M | Buy |
|
|||||
|
2024
Q3 | $82.4M | Sell |
|
|||||
|
2024
Q2 | $75.5M | Sell |
|
|||||
|
2024
Q1 | $74.9M | Buy |
|
|||||
|
2023
Q4 | $73.6M | Buy |
|
|||||
|
2023
Q3 | $60.6M | Buy |
|
|||||
|
2023
Q2 | $59.3M | Buy |
|
|||||
|
2023
Q1 | $49.1M | Buy |
|
|||||
|
2022
Q4 | $58.4M | Buy |
|
|||||
|
2022
Q3 | $31.7M | Sell |
|
|||||
|
2022
Q2 | $32.7M | Buy |
|
|||||
|
2022
Q1 | $28.9M | Sell |
|
|||||
|
2021
Q4 | $28.2M | Sell |
|
|||||
|
2021
Q3 | $25.9M | Buy |
|
|||||
|
2021
Q2 | $43.2M | Buy |
|
|||||
|
2021
Q1 | $35.6M | Sell |
|
|||||
|
2020
Q4 | $52.4M | Sell |
|
|||||
|
2020
Q3 | $46.6M | Sell |
|
|||||
|
2020
Q2 | $59.3M | Buy |
|
|||||
|
2020
Q1 | $38.9M | Buy |
|
|||||
|
2019
Q4 | $65.1M | Sell |
|
|||||
|
2019
Q3 | $14.8M | Buy |
|
|||||
|
2019
Q2 | $16.8M | Buy |
|
|||||
|
2019
Q1 | $195K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $540K | Buy |
|
|||||
|
2016
Q4 | $908K | Buy |
|
|||||
|
2016
Q3 | $996K | Buy |
|
|||||
|
2016
Q2 | $856K | Buy |
|